Shotgun and targeted proteomics reveal that pre-surgery serum levels of LRG1, SAA, and C4BP may refine prognosis of resected squamous cell lung cancer

J Mol Cell Biol. 2012 Oct;4(5):344-7. doi: 10.1093/jmcb/mjs050.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Non-Small-Cell Lung / blood*
  • Carcinoma, Non-Small-Cell Lung / diagnosis
  • Carcinoma, Non-Small-Cell Lung / surgery
  • Carcinoma, Squamous Cell / blood*
  • Carcinoma, Squamous Cell / diagnosis
  • Carcinoma, Squamous Cell / surgery
  • Complement C4b-Binding Protein / metabolism*
  • Female
  • Glycoproteins / blood*
  • Humans
  • Lung Neoplasms / blood*
  • Lung Neoplasms / diagnosis
  • Lung Neoplasms / surgery
  • Male
  • Middle Aged
  • Prognosis
  • Proteomics
  • Serum Amyloid A Protein / metabolism*

Substances

  • C4BPA protein, human
  • Complement C4b-Binding Protein
  • Glycoproteins
  • LRG1 protein, human
  • Serum Amyloid A Protein